Literature DB >> 8989333

Delayed puberty in girls with cystic fibrosis despite good clinical status.

M Johannesson1, C Gottlieb, L Hjelte.   

Abstract

BACKGROUND: Previous studies have shown that puberty is delayed among patients with cystic fibrosis (CF). Malnutrition has been considered the main etiologic factor. Today with improved medical therapy and nutritional support, most CF patients obtain an almost normal nutritional status.
OBJECTIVES: To investigate whether pubertal development among female CF patients at the Stockholm CF Center was normal and, if not, what other parameters besides nutrition might influence this.
METHODS: Seventeen patients were studied retrospectively regarding age at peak height velocity and menarche. Menarcheal age (MA) was compared with normal population data and related to clinical and nutritional status, genotype, oral glucose tolerance test (OGTT), and essential fatty acid levels.
RESULTS: The mean age at peak height velocity (12.9 +/- 0.8 years) and at menarche (14.9 +/- 1.4 years) was significantly higher in the CF patients compared with normal controls (11.9 +/- 1.0 years and 13.0 +/- 1.0 years, respectively). No correlation was found between menarchal age and nutritional or clinical parameters. The patients with pathological OGTT without overt diabetes were significantly older at menarche (15.8 +/- 1.7 years) compared with the patients with normal OGTT (14.3 +/- 0.9 years). The patients who were homozygous for the most common mutation, deltaF508, were significantly older at menarche (15.2 +/- 1.9 years) than those who were not (14.7 +/- 0.9 years).
CONCLUSIONS: Pubertal delay still existed among the CF patients despite good clinical status. The patients homozygous for deltaF508 and those with pathological OGTT showed the most delayed puberty.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8989333     DOI: 10.1542/peds.99.1.29

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  22 in total

1.  Normal growth in cystic fibrosis associated with a specialised centre.

Authors:  C E Collins; L MacDonald-Wicks; S Rowe; E V O'Loughlin; R L Henry
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  Growth and growth charts in cystic fibrosis.

Authors:  Leena Patel; Moira Dixon; T J David
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

3.  Pubertal Height Growth and Adult Height in Cystic Fibrosis After Newborn Screening.

Authors:  Zhumin Zhang; Mary J Lindstrom; Philip M Farrell; HuiChuan J Lai
Journal:  Pediatrics       Date:  2016-04-05       Impact factor: 7.124

4.  Menarche in pediatric patients with Crohn's disease.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Eric Vittinghoff
Journal:  Dig Dis Sci       Date:  2012-06-29       Impact factor: 3.199

5.  Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors:  Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

6.  Cystic fibrosis Δf508 mutation screening in Brazilian women with altered fertility.

Authors:  G V F Brunoro; E V Wolfgramm; I D Louro; I I Degasperi; V C W Busatto; A M S Perrone; M C P Batitucci
Journal:  Mol Biol Rep       Date:  2010-11-26       Impact factor: 2.316

7.  Pubertal height velocity and associations with prepubertal and adult heights in cystic fibrosis.

Authors:  Zhumin Zhang; Mary J Lindstrom; HuiChuan J Lai
Journal:  J Pediatr       Date:  2013-03-25       Impact factor: 4.406

8.  Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.

Authors:  Troy D Pashuck; Sarah E Franz; Molly K Altman; Clive H Wasserfall; Mark A Atkinson; Thomas J Wronski; Terence R Flotte; Michael S Stalvey
Journal:  Pediatr Res       Date:  2009-03       Impact factor: 3.756

Review 9.  Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Authors:  Oranan Siwamogsatham; Jessica A Alvarez; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

10.  Cystic fibrosis and estrogens: a perfect storm.

Authors:  Pamela L Zeitlin
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.